Table 1.

Baseline characteristics and comorbidities.

	Simvastatin (n = 56)	Control (n = 54)	P value
Gender (male/female)	20/36	22/32
Age (year)	56.1 ± 11.1	51.4 ± 12.9	0.131
Weight (kg)	56.8 ± 7.9	58.6 ± 8.7	0.245
Height (cm)	161.4 ± 6.3	163.4 ± 5.9	0.094
CPB duration (min)	115.4 ± 28.7	110.8 ± 36.8	0.464
Aorta clamping duration (min)	79.2 ± 22.26	73.9 ± 29.6	0.296
Atrial fibrillation (persons)	14	12	0.847
Diabetes (persons)	2	3	0.742
Ejection fraction EF (%)	60.32 ± 14.97	60.2 ± 6.61	0.958
Cardiac function (NYHA class)			0.704
I	3	4
II	14	15
III	38	33
IV	1	2
Blood lipid level
Total cholesterol (mmol/L)	4.56 ± 0.90	4.79 ± 0.84	0.171
Triglyceride (mmol/L)	1.15 ± 0.32	1.26 ± 0.29	0.056
Low density lipoprotein (mmol/L)	2.65 ± 0.56	2.78 ± 0.48	0.187
High density lipoprotein (mmol/L)	1.21 ± 0.24	1.24 ± 0.31	0.469

Data expressed as mean ± standard deviation. CPB: cardiopulmonary bypass; NYHA: New York Heart Association.